Compound information
- Natural Products
- NACP37249
- Molecular Formula
- C21H33N5O5
- Molecular Weight
- 435.248169156 g/mol
- Structure
-
- IUPAC Name
- 2-[6-(benzyloxycarbonylamino)hexanoylamino]-6-guanidino-hexanoic acid
- InChI
- InChI=1S/C21H33N5O5/c22-20(23)24-13-8-6-11-17(19(28)29)26-18(27)12-5-2-7-14-25-21(30)31-15-16-9-3-1-4-10-16/h1,3-4,9-10,17H,2,5-8,11-15H2,(H,25,30)(H,26,27)(H,28,29)(H4,22,23,24)
- InChI Key
- GERRYTJYUNNIQZ-UHFFFAOYSA-N
- SMILES
- O=C(OCC=1C=CC=CC1)NCCCCCC(=O)NC(C(=O)O)CCCCNC(=N)N
- CAS
- 352663-29-7
- SuperClass
- Organic acids and derivatives
- Class
- Carboxylic acids and derivatives
- SubClass
- Amino acids, peptides, and analogues
- Source
- CNP0401750
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 31 | Ring Count | 1 |
Heteroatom Count | 10 | Rotatable Bond Count | 15 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 6 |
Topological Polar Surface Area | 166.63 Å2 | LogP | -0.247 |
LogS | -2.729 | LogD | 0.304 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.004 | Pgp substrate | 0.992 |
HIA | 0.0 | F20 % | 0.041 |
F30 % | 0.0 | Caco-2 | -6.194 |
MDCK | -5.982 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.964 | PPB | 80.133 |
VD | 0.427 | Fu | 0.123 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.378 |
CYP2A6 substrate | 0.275 | CYP2B6 substrate | 0.431 |
CYP2C19 inhibitor | 0.06 | CYP2C19 substrate | 0.467 |
CYP2C8 substrate | 0.472 | CYP2C9 inhibitor | 0.391 |
CYP2C9 substrate | 0.027 | CYP2D6 inhibitor | 0.32 |
CYP2D6 substrate | 0.289 | CYP2E1 substrate | 0.172 |
CYP3A4 inhibitor | 0.054 | CYP3A4 substrate | 0.072 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.698 | CL | 4.455 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.191 | Hepatotoxicity | 0.043 |
Mutagenicity | 0.004 | Rat Oral Acute Toxicity | 0.033 |
FDAMDD | 0.075 | Skin Sensitization | 0.117 |
Carcinogenicity | 0.001 | Eye Corrosion | 0.002 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.014 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.042 | IGC50 | 2.334 |
LC50FM | 3.866 | LC50DM | 2.884 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.205 | NR-AR-LBD | 0.226 |
NR-AhR | 0.003 | NR-Aromatase | 0.026 |
NR-ER | 0.275 | NR-ER-LBD | 0.365 |
NR-PPAR-gamma | 0.484 | SR-ARE | 0.092 |
SR-ATAD5 | 0.353 | SR-HSE | 0.167 |
SR-MMP | 0.009 | SR-p53 | 0.031 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.